Sky Labs
VUNO, Kakao Healthcare, Skylabs, and Remidio advance into Europe with partnership deals and regulatory approvals for AI in cardiac, chronic, and eye care.
        
        
          Despite a dry investment climate, it was able to secure what could be the biggest funding raise by a health tech company in South Korea this year.
        
        
          Also, Vuno is developing health content for chronic disease patients on Hativ Care. 
 
        
        
          The company targets to receive a similar clearance from the US FDA by yearend.
        
        
          
        SPONSORED
            
      
                    
            
  New research finds using a smartphone app more than doubles detection and treatment rates in older people
        
        
          
        SPONSORED
            
      
                    
            
  Telehealth was vital to the pandemic response, with much of the enabling technology already in place. Its role in maintaining care and monitoring patient health at a time of shielding, social distancing and remote working anticipated wider benefits.
        
        
          
        SPONSORED
              
      
                    
            
  A smart ring-type heart-monitoring device is targeting the global market.
        
        
          Also, South Korean startup Lunit obtains two new US FDA approvals for its AI diagnostic tools.
        
        
          The startup, known for its ring-type heart-monitoring device, recently raised $20 million in a Series B funding round.
        
        
           
 
 
 
 

 
 
